Test ID: CDAU2
Drug Abuse Survey with Confirmation, Evaluation 2, Urine
Method Description
Describes how the test is performed and provides a method-specific reference
Screening is performed by immunoassay (see IDOAU/8248 Drug Abuse Survey, Urine). All positive screening results are confirmed by gas chromatography-mass spectrometry before a positive is reported. (Armbruster DA, Schwarzhoff RH, Hubster EC, Liserio MK: Enzyme immunoassay, kinetic microparticle immunoassay, radioimmunoassay, and fluorescence polarization immunoassay compared for drugs-of-abuse screening. Clin Chem 1993;39:2137-2146; Ellis GM Jr, Mann MA, Judson BA, et al: Excretion patterns of cannabinoid metabolites after last use in a group of chronic users. Clin Pharmacol Ther 1985;38:572-578; Foerster EH, Dempsey J, Garriott JC: A gas chromatographic screening procedure for acid and neutral drugs in blood. J Anal Toxicol 1979;3:87-91; as modified to incorporate some alkaline drugs by LE Ebnet and TP Moyer, Mayo Clinic)
Day(s) and Time(s) Test Performed
Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Monday through Sunday


